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HIV infection profoundly affects many parameters of the immune system and ultimately
leads to AIDS, yet which factors are most important for determining resistance, pathology,
and response to antiretroviral treatment – and how best to monitor them – remain unclear.
We develop a quantitative high-throughput sequencing pipeline to characterize the TCR
repertoires of HIV-infected individuals before and after antiretroviral therapy, working from
small, unfractionated samples of peripheral blood. This reveals the TCR repertoires of
HIV+ individuals to be highly perturbed, with considerably reduced diversity as a small
proportion of sequences are highly overrepresented. HIV also causes specific qualitative
changes to the repertoire including an altered distribution of V gene usage, depletion
of public TCR sequences, and disruption of TCR networks. Short-term antiretroviral
therapy has little impact on most of the global damage to repertoire structure, but is
accompanied by rapid changes in the abundance of many individual TCR sequences,
decreases in abundance of the most common sequences, and decreases in the majority
of HIV-associated CDR3 sequences. Thus, high-throughput repertoire sequencing of
small blood samples that are easy to take, store, and process can shed light on various
aspects of the T-cell immune compartment and stands to offer insights into patient
stratification and immune reconstitution.
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1. INTRODUCTION
During the chronic phase of HIV infection, viral load and total T-cell numbers remain relatively
stable. However, analysis of T-cell turnover reveals a more dynamic picture, with continuous virus
turnover and rapid CD4 cell death offset by increased T-cell proliferation (1). HIV infection typically
leads to development of AIDS, although this can be prevented with combination antiretroviral
therapy (ART). ART rapidly reduces viremia to very low or undetectable levels and is associated
with a long-term increase in peripheral blood CD4 T-cell numbers and reduced risk of secondary
infections (2). In this study, we examine the structure of the T-cell receptor (TCR) repertoire in
chronically infected treatment-naïve individuals and monitor the changes that occur immediately
after viral replication is blocked by ART.
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HIV infection affects many features of the immune system, and
it remains unclear which changes are ultimately responsible for
different aspects of the pathology. HIV infection of CD4 T-cells
leads to an increased rate of cell death by both direct virological
and indirect immunological mechanisms (3, 4). HIV also drives
CD8+ antigen-specific clonal expansion as well as unspecific cell
activation and exhaustion (5, 6).
Many studies have investigated TCRs in HIV-infected indi-
viduals. Flow cytometry, DNA hybridization, and quantitative
PCR have shown decreased expression of certain V genes (7–10).
Spectratyping analysis has revealed a skewing of CDR3 length dis-
tributions in certain V families, indicating clonal expansions (11–
13). A decrease in TCRdiversity associatedwithHIV infection has
also been measured using a number of experimental approaches
(14–16), although such observations have typically been limited to
either antigen- or subset-specific populations. The overall impact
of viral cytotoxicity, viral antigenicity, and immune escape on
the clonal structure of the T-cell population remain incompletely
understood.
The introduction of high-throughput DNA sequencing allows
analysis of the TCR repertoire at greater depth than previous
techniques, with quantitative, nucleotide-level resolution (17, 18).
Previous analysis of TCR repertoires from HIV patients often
involved complex cell fractionation protocols, which pose a chal-
lenge in a routine clinical setting. However, we demonstrate that
high-throughput analysis of TCR repertoire profiles from unsep-
arated whole blood samples can reveal multiple levels of dysreg-
ulation in HIV patients. The diversity of the TCR repertoire is
profoundly diminished during chronic infection, with expansion
of large private clones driving the formation of highly idiosyn-
cratic repertoires. HIV infection is also associated with skewing
of V gene usage and disruption of the population structures
that typify healthy repertoires. These perturbations remained
largely unchanged after 3months of ART, despite viral load being
reduced to undetectable levels in most patients coincident with a
significant increase in CD4 T-cell numbers. However, ART was
accompanied by major changes at the sequence level, with many
rapid, dramatic changes of frequency. Diverse immunological
parameters and rapid restructuring events can therefore be cap-
tured from even small blood samples, which stands to offer new
methods to monitor immune perturbation and reconstitution in
patients suffering from infectious or immunodeficient conditions.
2. MATERIALS AND METHODS
2.1. Study Design
This laboratory study aimed to test whether and how deep
sequencing of TCR repertoires from HIV patients might pro-
duce results of interest to clinical and immunological inves-
tigations. Adult HIV+ ART-naïve patients due to start treat-
ment were recruited, with the first sixteen eligible candidates
being processed. Exclusion criteria included febrile or AIDS-
related illness; tumors; coinfection with Hepatitis B or C;
immunomodulatory therapy, recent vaccination, or breaks in
treatment. 2.5ml of peripheral blood was drawn into Tempus
tubes, and RNA was extracted as per the manufacturer’s instruc-
tions (Life Technologies). Residual gDNA was removed using
the TURBO-DNase kit, and globin mRNA was depleted using
GLOBINclear (Life Technologies). RNA was likewise prepared
from consenting adult healthy controls. Human participation in
this study was approved by UK Research Ethics Committee. All
subjects gave written informed consent in accordance with the
Declaration of Helsinki.
2.2. Unbiased TCR Amplification and
Sequencing
Our protocol amplifies all rearrangements (within a chain) with
a single primer pair, thus avoiding primer bias (Figure S1 in
SupplementaryMaterial). Addition of molecular barcodes to each
cDNA molecule allows further correction for PCR amplifica-
tion and errors. Primer sequences are shown in Table S1 in the
Supplementary Material.
RNAwas reverse transcribed using oligonucleotides (αRC2 and
βRC2) directed against each constant regions’ 50. 500 ng of RNA
was mixed with 1μl of each RC2 primer (10μM) and 1μl of a 10-
mM dNTPmix and heated at 65°C, 5min before rapid cooling on
ice. 1μl of DTT (0.1μM), 1μl of RNasin (20–40U/μl, Promega),
1μl of SuperScript III reverse transcriptase (RT) (200U/μl, Life
Technologies) and 4μl of 5 FS buffer were added, before incu-
bation at 55°C, 20min, then heat inactivated at 70°C, 15min.
RT reactions were purified and eluted into 10μl of Tris-Cl using
MinElute columns (Qiagen).
cDNA was ligated to a 50 RACE adapter, incorporating a
random hexamer and SP2, one of the two sequencing primer
sites, in 30μl: 1 T4 RNA ligase buffer; 20U T4 RNA Ligase 1
(NEB); 0.33mM dATP; 25% PEG 8000; 1mM hexammine chlo-
ride; 0.1mg/ml acetylated-BSA, 0.33μMSP2-6N ligation oligonu-
cleotide and 5μl of purified cDNA. Ligations were incubated for
23 h at 16°C and heat inactivated for 10min at 65°C. Products
were diluted with 70μl of water and purified using a 1:1 ratio of
AMPure XP beads (Beckman Coulter), eluting in 30μl of water.
Ligated DNA underwent second strand synthesis, priming off
SP2. Final concentrations in 50μl were 0.2μM dNTPs, 0.5μM
SP2, and 1U Phusion, in 1X HF buffer. Thermal conditions were
95°C, 3min; a slow ramp to 80°C, 10 s; another slow ramp to
58°C, 45 s; and final extension for 5min at 72°C. Slow ramping
involves descending at 0.5°C/s to encourage optimal annealing
at the highest temperature. Bead-purified samples were split in
two for separate chain-specific third strand synthesis. Reaction
conditions were the same as the second strand reaction, except
the SP2 primer was replaced with either SP1-6N-Ix-αRC1 or
SP1-6N-Ix-βRC1 (“x” being a multiplexing index). Bead-purified
samples then underwent “PCR1” to add the P5 and P7 elements:
0.2mM each dNTP, 0.5μM of each primer (P5-SP1 and P7-X-
SP2), and 1U Phusion in 1XHF buffer (“X” being another index).
Initial denaturation was at 95°C for 3min, before ramping slowly
to 69°C, 15 s, and extended at 72°C, 1min, before 3 cycles of
98°C, 10 s to 72°C, 1min. Final extension was at 72°C for 5min.
Purified products were then subjected to “PCR2,” to amplify to
sufficient concentrations. Reaction conditions were the same as
in PCR1, except primers used were P5s and P7. The PCR pro-
gram began with initial denaturation at 95°C, 3min, before 23
cycles of: 98°C, 10 s; 69°C, 15 s; 72°C, 40 s, then final extension
at 72°C for 5min and bead purification. Samples thus received
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27 cycles of PCR in total. Final products were quantified on a
Qubit (Life Technologies) and sized on a Bioanalyzer (Agilent)
before dilution to 4 nM. Normalized libraries were sequenced on
an Illumina MiSeq, using 2 250 PE kits.
2.3. Data Analysis
Demultiplexed FASTQ files were analyzed using a modified ver-
sion of the TCR assignation software Decombinator, developed
previously in our lab (19). This modified Decombinator addi-
tionally outputs barcode sequence information (comprised of the
two random hexamer sequences added prior to amplification,
concatenated together) in addition to the V, J, and insert infor-
mation. This barcode information is then used to error-correct
the TCR sequences: as the probability of any two identical TCRs
acquiring the same 12-mer barcode (from the 412 possibilities) is
low, sequences that share a barcode and yet do not match themost
frequent (within a 20% nucleotide identity threshold across the
Decombinator-definedV–J spanning sequence) are assumed to be
PCR or sequencing errors, and are discarded. Then, by counting
the number of barcode sequences that are associated with a given
rearrangement (clustering barcodes with a Levenshtein distance
of 3 to allow for errors in the barcode sequence itself), we can esti-
mate howmany original cDNAmolecules encoded the same TCR
chain, reducing the impact of PCR duplication. Decombinator
and error-correction scripts werewritten in Python. All remaining
analyses were carried out in R, using the following packages:
ineq (Gini index calculation), vegan (diversity indices), and
igraph and RCytoscape (network/cluster analysis). IMGT TCR
nomenclature and CDR3 definition (running from the last con-
served cysteine in the V to the conserved phenylalanine in the
FGXGmotif in the J gene) have been used throughout (20). HIV-
associated CDR3s were harvested from references (6, 21–38) and
MAIT sequences from references (39, 40), while CMV-associated
sequences were obtained via reference (41). Statistical significance
was determined using T test (paired or unpaired as appropriate)
except where indicated.
2.4. Data Availability
FASTQ data are available from the Sequence Read Archive,
accession number SRP045430. Processed TCR data and
published antigen-/subset-specific CDR3s are available
for download (DOIs: 10.6084/m9.figshare.1153921 and
10.6084/m9.figshare.1153817). TCR analysis scripts are freely
available (DOI: 10.6084/m9.figshare.11908611), as is the standard
version of Decombinator ((19), RRID:OMICS_000012).
3. RESULTS
Two unfractionated blood samples were taken from HIV+
patients – one immediately prior to (S1) and another 3months
after commencing ART (S2) – from which RNA was extracted.
Ten uninfected donors were also sampled as controls, four of
whom were sampled twice 3months apart. RNA was reverse
1https://github.com/JamieHeather/tcr-analysis
2https://github.com/uclinfectionimmunity/Decombinator/
transcribed, and cDNA molecules were labeled with molecu-
lar barcodes before amplification and sequencing (Figure S1 in
Supplementary Material).
Patient CD4 counts showed amodest but significant increase in
most individuals (14/16) after 3months of therapy, yet remained
below normal values (Figure S2A in Supplementary Material).
CD8 counts showed no consistent change over this period, while
the CD4:CD8 T-cell ratio slightly increased (Figures S2B,C in
Supplementary Material). Viral genome counts decreased rapidly
and were undetectable in 11/16 individuals by the second sam-
ple collection (Figure S2D in Supplementary Material) and in
all patients after a further year of ART. Clinical data and the
number of sequences obtained are summarized in Table S2 in the
Supplementary Material.
3.1. HIV+ TCR Repertoires Show a
Profoundly Decreased Richness and
Diversity Which Does Not Recover During
Short-Term ART
The complementarity determining region 3 (CDR3) section of
a given T-cell receptor is that which is encoded at the hyper-
variable recombination junction, and forms the primary contacts
with the peptide-MHC antigen (42). Therefore, as the major site
of biological interest, it is the primary sequence investigated in
this study. There is no significant difference in the total number
of TCR CDR3 sequences of either chain between HIV  and
HIV+ repertoires (Figure 1A), in agreement with the lack of
total T-cell lymphocytopenia in these patients. In contrast, there
is a significant decrease (p 0.01) in the number of distinct
sequences observed (Figure 1B), as HIV+ samples contain on
average threefold fewer sequences per chain. The TCR reper-
toire is determined both by the number of different sequences
(richness) and the relative abundances of each clonotype. The
combination of these properties is typically quantified as diversity,
with decreased diversity likely reflecting a decreased ability of
the repertoire to recognize and respond across the spectrum of
potential pathogen antigens (43). One frequently used measure of
diversity is the Shannon information index, or Shannon entropy,
which is significantly decreased (p< 0.01) in untreated HIV+
repertoires (Figure 1C) and shows no recovery after therapy.
This low diversity shows a weak inverse correlation to viral load
(Pearson correlations: alpha chain R= 0.48, p= 0.06; beta chain
R= 0.41, p= 0.12). Random sampling of the same number of
sequences to produce size-matched repertoire files shows the same
significant decrease in diversity, thus it is not a feature of the lower
number of sequences found in patient repertoires (Figure S2E in
Supplementary Material).
3.2. Altered V Gene Usage in Chronic
HIV Infection
The distribution of V gene usage for both chains, measured for
distinct sequences (counting each TCR only once to avoid bias
from the effects of clonal amplification), is shown inFigures 2A,B.
As reported previously, the expression pattern of different V
genes is non-uniform and conserved between individuals (44–
46). Eight V alpha and eight V beta genes showed significant
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FIGURE 1 | The repertoires of HIV-infected individuals have a smaller number of distinct sequences, and lower diversity. (A) The total number of alpha
(left) and beta chain (right) CDR3 sequences obtained from each HIV  and HIV+ individual, at both the pretreatment (S1) and treated (S2) bleed. The bars show
mean and SD. (B) As for (A) but showing the number of unique CDR3 sequences observed within each set. The difference between the mean of the HIV  and HIV+
S1 samples was significant, p<0.01. There was no significant difference between HIV+ S1 and HIV+ S2. (C) As for (A) but showing CDR3 diversity measured by
the Shannon information index (or Shannon entropy) for each sample.
differences in mean expression between patients and controls,
suggesting that HIV infection might differentially modulate cer-
tain parts of the repertoire, for example by driving expansion
of HIV (or coinfecting pathogen) reactive T-cells using specific
genes. A recent repertoire analysis of Treg cells sorted from HIV-
infected individuals (47) showed a similarly non-uniform V and J
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FIGURE 2 | Altered distribution and interindividual differences in V gene usage in the repertoires of HIV+ individuals. The frequency of V alpha (A) and
V beta (B) gene usage for the unique TCR repertoires of each donor sample within the two groups (HIV  in black or untreated HIV+ in red). Bars show the mean
proportion for each V gene in each group. Asterisks (*) show those V genes, which differ significantly in their usage (T test, p<0.05) between HIV  and HIV+.
Interindividual differences in patterns of V gene usage (measured using Jensen–Shannon distances) for alpha (C) and beta (D) V genes. The plot shows the median
and interquartile range of the Jensen–Shannon distances between each individual and all other individuals in turn from the same group. HIV  are shown in black;
HIV+ are shown in red.
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gene distribution, with many of the most frequently used V genes
observed in that study being similarly over represented in this
study (e.g. TRBV6-5).
V gene usage profiles between HIV+ repertoires also differed
by a greater amount than between healthy volunteer repertoires.
This was measured by calculating Jensen–Shannon distances for
each pair of V gene usage distributions; HIV+ pairs showed
greater distances than HIV  pairs (Figures 2C,D). Chronic HIV
infection therefore leads to severe idiosyncratic perturbations of
T-cell compartments, driving each individual’s repertoire away
from typical ranges into their own distinct state. In contrast, the
distributions of J gene differences showed few significant differ-
ences between HIV+ and HIV  repertoires (Figure S3 in Supple-
mentaryMaterial). This may reflect the shorter length and greater
propensity for base removal during recombination in the J genes
relative to the V genes, and in the case of beta chain sequences,
there being far fewer J genes for rearrangements to draw upon.
Comparing the distribution of V genes of HIV+ repertoires
before and after therapy revealed that those relatively perturbed
genes tended to return towards healthy values (Figure S4 in
Supplementary Material) but changes observed were small.
3.3. Decreased TCR Sequence Sharing
Between Repertoires of HIV+ Individuals
Despite the stochasticity inherent in V(D)J recombination, TCR
sequences can often be found to be shared between individuals,
being classified as private when they occur in only a few individ-
uals and public when found in many (45, 48–51). To see whether
HIV infection impacts upon TCR sharing, we first compared the
proportion of CDR3s shared between pairs of HIV+ individuals
to that of HIV  pairs by using the Jaccard index (a normalized
measure of sharing, Figure 3A), which revealed a profound loss of
sharing among HIV-infected patients relative to healthy controls.
This property is not a feature of sample size, as size-matching
data by random selection shows the same result (Figure S5A in
Supplementary Material). Similarly, by counting the number of
CDR3s that occur in 5 or more out of 10 HIV  or HIV+ individ-
uals, we see a decrease in the number of highly shared sequences
(Figure 3B), again indicating a loss of TCR sharing betweenHIV+
patients and a tendency toward idiosyncratic repertoires. Figure
S5B in Supplementary Material shows the intradonor Jaccard
indices (i.e., the overlap of each individual’s S1 and S2 samples)
for reference.
3.4. HIV Infection Is Associated with
Disruption of Networks of Similar CDR3s
In order to explore the connectivity betweenCDR3s, wemeasured
the distance between every pair of CDR3 amino acid sequences
in an individual, using the Levenshtein distance (the minimum
number of changes required to turn one sequence into another).
We then constructed networks by creating an edge between
unique CDR3 sequences (nodes), which differ by a distance of
one (Figure 3C; Figure S6 in SupplementaryMaterial). The size of
the largest alpha CDR3 network (cluster size) and the maximum
number of edges going to any one node (the maximal degree) for
each individual are shown in Figures 3D,E. Themaximum cluster
size and the maximum network degree in the HIV+ repertoires
are much smaller than the largest clusters in the uninfected reper-
toires, indicating landscapes of CDR3s that are less similar than
those seen in controls. Healthy donor alpha repertoires are more
similar, revealed by increased frequency of CDR3s, which differ by
a Levenshtein distance of five or less (Figure 3F). No differences
were seen between patients and controls for these parameters in
the beta chain networks (Figure S7 in Supplementary Material),
perhaps reflecting the greater diversity of the beta sequences
owing to the presence of TRBD genes.
3.5. ART Is Accompanied by Large
Changes in the Abundances of Individual
Alpha and Beta Chain Sequences
By averaging the 100 most common sequences per donor, we
observed that the most abundant CDR3s in HIV+ samples are
significantly more frequent than controls (Figure 4A; Figure S8A
in Supplementary Material). While the average frequency falls
slightly following therapy, it remains higher and more variable
than in HIV  controls. These highly abundant sequences skew
the repertoire frequency distributions of HIV+ individuals, with
the most common sequences in patients occupying over twice as
much of the repertoire than the most common sequences found
in uninfected controls (Figure 4B).
The Gini index is a measure of unevenness that can measure
this skewness, which ranges from zero for a uniform population
(all TCRs being equally present) and tending toward one (maxi-
mum inequality). The mean Gini index is significantly increased
in HIV+ samples compared to the healthy controls (Figure 4C),
which could be considered reflective of increased oligoclonality.
In contrast to the diversity as measured by Shannon entropy,
the mean Gini index shows a significant recovery following ther-
apy, yet remains above the mean of healthy controls. However,
this observation is not replicated in size-matched data (Figure
S8B in Supplementary Material). Interestingly, the Gini indices
of the pre-treatment patient data significantly correlate to their
CD8 counts (alpha R= 0.63, p= 0.01; beta R= 0.50, p= 0.05) but
are independent of CD4 counts (alpha R= 0.21, p= 0.44; beta
R= 0.06, p= 0.81). It is worth noting that the slight differences
between the age and sex profiles of our control and uninfected
donor cohorts fail to explain the differences observed in either
measure of diversity (Figure S9 in Supplementary Material).
Because of the degeneracy of the genetic code and the sim-
ilarity of germline TCR genes, identical CDR3s can be created
by multiple DNA sequences (here referred to as translational
convergence). By plotting the average number of different TCR
rearrangementswhich translate to produce the 100most abundant
CDR3s in each group, we see lower translational convergence in
the patient group (Figure 4D). Thus, despite the abundant CDR3s
in HIV patients being far more frequent, they are translated from
fewerDNA sequences. This suggests that abundant CDR3s inHIV
patients arise from large clonal expansions.
We tracked the frequencies of the 100most abundant sequences
per chain before and after therapy (example donors shown in
Figure 5, with all donors in Figure S10 in Supplementary Mate-
rial). Frequency histograms of the ratio of sequence abundance
in S2 versus S1 (Figure 5B) show that HIV+ samples show
more dispersion than controls, indicating that these sequences
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FIGURE 3 | TCR repertoires of HIV+ individuals show less sequence sharing and reduced TCR similarity networks.
(Continued)
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FIGURE 3 | Continued
(A) The proportion of shared sequences (the Jaccard index) between the repertoires of each pair of HIV  and HIV+ individuals, at either time point (pre- or
mid-treatment, S1 and S2, respectively). T test: **p<0.01, *p<0.05. (B) The number of CDR3s, which are shared between 5, 6, 7, 8, 9, or 10 out of ten HIV 
(black) or HIV+ (gray) individuals. In order to correct for the larger size of the HIV+ cohort (16 HIV+ versus 10 HIV ), the plot shows the average results of analyzing
100 random samples of 10 out of the 16 samples available. (C) A network plot showing clusters of related alpha chain CDR3s from a representative HIV  or HIV+
repertoire. Each node represents a unique CDR3, and the diameter of the node represents the number of CDR3s in the repertoire. Two CDR3 nodes, which differ
from each other by a Levenshtein distance of 1 are connected by an edge. The 100 most abundant CDR3s in each repertoire are shown in gray. Only clusters with
three or more nodes are shown. The largest alpha chain cluster size (D) and the maximum degree (E) in each HIV  or HIV+ repertoire before (S1) and after (S2)
therapy. Bars show mean and SD. Means of HIV  and HIV+ differ significantly (**p<0.01). (F) The frequency distribution of CDR3s, which differ by a Levenshtein
distance of 1–5 in HIV+ (black) or HIV  (gray) repertoires.
undergo larger frequency changes compared to themost common
sequences in uninfected donors.
The histogram of the HIV+ samples shows one peak close
to 1 (similar to HIV  histograms) and another near 0.01, i.e.,
a decrease of approximately 100-fold. These changes occurred
over 14weeks which translates to a half-life on the order of
30 days, compatible with the known half-life of effector memory
T-cells (52).
3.6. Mucosal-Associated Invariant T-Cell
Sequences Are Depleted in HIV+
Repertoires and Do Not Recover
Following ART
We searched our data for sequences belonging to non-MHC
restricted T-cell subsets, many of which use TCRs which include
“invariant” alpha chains, those which use a tightly conserved
selection of V and J genes and near-identical CDR3s. Sequences
associated with invariant natural killer T (iNKT) and germline-
encodedmycolyl lipid-reactive (GEM) cells were extremely rare in
our data, consistent with a reported very low frequency in blood.
In contrast, CDR3s derived from mucosal-associated invariant
T (MAIT) cells – which can constitute upwards of 10% of the
healthy CD8+ T-cell pool (53) – were present in the context of
the correct genes (TRAV1-2 with TRAJ33, TRAJ12, or TRAJ20) at
high frequencies in healthy controls (Figure 6A). MAIT CDR3s
were severely depleted in HIV+ repertoires and showed no evi-
dence of recovery following therapy. V genes from beta chains
known to pair with the invariant MAIT alpha chains (TRBV6-1
and TRBV20-1) (39) were among the few that were significantly
decreased in the repertoires of HIV-infected donors (Figure 2A).
3.7. ART Induces Rapid Changes in the
Numbers of HIV- and CMV-Associated
CDR3s
While this study was not designed to gather alpha-beta chain
pairing information, there are a number of reports in which even
single chains from T-cells reactive against a particular antigen
share sequence identity or features, and some TCRs can recognize
the same peptide in the context of different MHC molecules
(26, 54–56). Furthermore, there are several published reports
of HIV-specific public TCR responses (21, 32, 33), sometimes
even finding the same CDR3 in combination with different V
and J genes (57). We therefore collected the CDR3 sequences
of HIV-specific T-cells from the literature (92 alpha and 702
beta) and searched for matches in our data. A set of CDR3s from
CMV-specific T-cells were also collected (13 alpha and 253 beta),
as an example of another chronic virus known to drive large
oligoclonal expansions (58–60). Because these sequences were
typically obtained by isolating viral-specific pMHC-tetramer+
cells, the HLA restriction of the set was highly skewed to a small
number of different genotypes.
We detected 15 examples of expanded HIV-associated CDR3s
in our data (equal to or greater than five copies in at least one
of a patients’ bleeds), comprised of 11 different CDR3s found
across seven different individuals (Figure 6B). Some individuals
had multiple matches, perhaps reflecting a match between their
HLA type (not determined here) and those used to originally
isolate the sequences. We found 17 examples of expanded CMV-
associated CDR3s, comprised of ten different CDR3s observed in
eight individuals. There was considerable overlap between the set
of patients containing HIV- and CMV-associated CDR3s, again
perhaps reflecting HLA genotype. Only two virally associated
CDR3s were found in this analysis in the uninfected repertoires
and only at the edge of detection at a single time point. As a
control, we selected ten similarly sized sets of CDR3s from an
independent published set derived from patients with Juvenile
Idiopathic arthritis (61). Only an average of 4.5 of these CDR3s
(SD of 0.8) were found in our patients, suggesting the viral-
associated CDR3 frequencies do indeed reflect actual virus expo-
sure. Over the course of therapy, HIV-associated CDR3s signifi-
cantly decreased in frequency, while CMV-associated sequences
did not significantly alter (Figures 6C,D), although the majority
of them (12 out of 17) did become more frequent.
4. DISCUSSION
We have developed a high-throughput sequencing pipeline to
measure quantitative parameters of the TCR repertoires of a
cohort of HIV-infected patients, before and 3months after the
start of antiretroviral therapy. From a small unsorted blood sam-
ple, we are able to extract tens of thousands of TCR sequences
per donor, providing the most comprehensive view of the global
impact of HIV infection upon the TCR repertoire to date. Despite
a relatively small cohort size, the results robustly identify multiple
aspects of immune dysregulation and document some interesting
changes that follow initiation of ART.
Dynamic changes in the TCR repertoire are a common fea-
ture of many viral infections. However, chronic HIV infection
presents a number of special characteristics. During chronic HIV
infection, the repertoire is severely restricted, averaging threefold
fewer distinct sequences than uninfected controls. This depletion
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FIGURE 4 | HIV+ repertoires have a skewed TCR chain abundance distribution.
(Continued)
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FIGURE 4 | Continued
(A) The mean abundance of the 100 most abundant alpha (left) and beta chain (right) CDR3s in HIV  and HIV+ before (S1) and after (S2) therapy. Bars show SD. T
test: **p<0.01, *p<0.05. (B) Size distribution of TCR chain abundances. The plot shows the proportion of alpha or beta sequences in the HIV  and HIV+ groups
before (S1) and after (S2) therapy, which fall within each 10 percentile range of the size distribution. The percentile ranges are shown in decreasing order from the
largest 10% (red) to the smallest 10% (yellow at top of each bar stack). (C) The Gini index of the TCR alpha or beta chain abundance distributions in HIV  and HIV+
before (S1) and after (S2) therapy. T test: ***p<0.001, **p<0.01, and *p<0.05. (D) Average translational convergence of alpha and beta CDR3s in HIV+ and
HIV  repertoires. The HIV+ and HIV  distributions differ significantly (one-way ANOVA, p<0.01).
A
B
FIGURE 5 | Rapid changes in abundance of individual TCR sequences following ART. (A) Abundance of the 100 most common alpha and beta sequences
before (S1) and after (S2) ART therapy, in a representative HIV  and HIV+ individual. (B) Change in abundance of the 100 most common alpha and beta sequences
following ART, expressed as a ratio of abundance in S2 over the abundance in S1. Sequences absent in one of the two samples were assigned a size of 1 in that
sample, so that the ratio between the two samples did not become infinite.
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A
B
C D
FIGURE 6 | Changes in frequency of MAIT and virally associated CDR3 sequences in HIV repertoires and following ART. (A) Average numbers of the ten
most frequent MAIT alpha chain sequences in the HIV  (filled bars) and HIV+ repertoires before (dashed bars) and 3months after (open bars) the start of ART. All
sequences required an exact sequence match to a published MAIT CDR3 in the context of the correct germline V and J TCR genes. These genes are TRAV1-2 and
TRAJ33, with the exception of CAVRDGDYKLSF, which instead uses the non-canonical TRAJ20 pairing. (B) Published CDR3 sequences from T-cells reported to be
HIV or CMV specific were found in the repertoires of the HIV+ individuals shown. CDR3 sequences were only included if they occurred at an abundance of five or
greater in either of the two of a patient’s samples. Underlining indicates alpha chain sequences, the rest being beta chain. (C,D) The proportion that each CDR3 listed
in (B) occupies in the repertoires in which they were found, in both their pretreatment (S1) and midtreatment (S2) samples, for both HIV- and CMV-associated CDR3s
((C,D), respectively). Horizontal lines indicate mean frequencies. The average clone size of the HIV CDR3s in sample 2 was significantly less than the size in S1 (T
test, p<0.05).
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is consistent with the short life span of infected CD4+ T-cells (1,
62) and significant cell death in bystander uninfected cells early in
disease progression (3). The shrinkage of the repertoire is opposed
by an overexpansion of a small proportion of TCRs. The decrease
in CD4+ counts and CD4:CD8 ratios combined with the positive
correlation between Gini index and CD8+ T-cell count suggest
that repertoire skewing can be attributed both to the decline
in CD4 cells and large expansions, primarily in the relatively
oligoclonal CD8 compartment. This hypothesis needs to be tested
further by analyzing the TCR repertoire of sorted CD4 and CD8
T-cell populations, as well as various effector andmemory subsets.
It is also worth noting that large clonal expansions might not
necessarily be directed against HIV antigens but might recognize
those belonging to other common coinfections: indeed, there is
some evidence that the majority of T-cell responses in untreated
patients are not directed toward HIV peptides (63).
HIV infection was also associated with qualitative repertoire
changes. Repertories from healthy adults are characterized by
highly conserved non-uniform distributions of different V and J
genes, thought to reflect intrinsic features of the recombination
process (45, 49, 64). These distributions are significantly altered
in the repertoires of the HIV-infected individuals, which may
partially reflect dramatic depletion of some non-classical T-cell
subsets, such asMAIT cells, which preferentially use certainV and
J TCR genes. TheHIV-associated decrease inMAIT cells has been
reported previously (53, 65) and is consistent with the extensive
damage to the gastrointestinal immune compartment, which is
a feature of HIV infection (66, 67). Further studies looking at
the repertoires of gamma-delta T-cells – which are enriched in
gastrointestinal tissues (68) – and those of all T-cells from gut-
associated lymphoid tissue will be interesting in this regard.
Healthy repertories are also characterized by the presence of
public CDR3s, which are shared between many different individ-
uals (45, 48–51). We also observed that repertoires from healthy
donors contain sets of CDR3s with very similar amino acid
sequences and that these sets often contain some of the most
abundant CDR3s observed. Here, we observed that HIV infection
associateswith a profounddepletion both of the number ofCDR3s
shared between people and CDR3 similarity within individuals.
This decreased sharing may, in part, reflect differences in HLA
types between individuals, although we have no reason to believe
theHLAdiversity is greaterwithin theHIV cohort than among the
controls. It may also be driven by heterogeneity in the microbial
antigens presented over the course of infection, both in terms
of the HIV mutating and in the complement of other infections
a given patient has. The function of public CDR3s and CDR3
networks remain unknown, although both features have been
suggested to play a role in the maintenance of self-tolerance (50).
Disruption of these features may therefore aggravate the immune
dysregulation, which is a feature of chronic HIV infection.
ART is a rapid and effective means to lower viral burden and
initiate restoration of immune function. Paradoxically, recovery of
themany parameters of immune function (e.g. CD4 count) occurs
much slower, requiring years to return to normal ranges, likely
related to low adult thymic output. TCR diversity and gene usage
patterns are at best only partially restored after 3months of ART.
However, at an individual sequence level, initiation of therapy is
accompanied by many rapid sequence expansions and contrac-
tions, including a reduction in the frequency of HIV-associated
CDR3s. The T-cell receptor repertoire is therefore highly dynamic
and undergoes substantial reshaping, which accompanies the
rapid fall in viral load. Further functional studies will be needed
to establish the causal relationship between the individual clonal
dynamics and the increased ability to control opportunistic infec-
tions, which results from ART. It will also be instructive to obtain
longer follow up samples from the HIV-infected cohort to doc-
ument the long-term reconstitution of the immune repertoire.
In particular, it will be interesting to see if the aberrant clonal
expansions observed in the HIV repertoires remain and play any
role in the chronic inflammatory phenotype, which seems to
contribute to long-term morbidity in HIV-infected individuals,
even when viral load is controlled.
This study only processed blood from sixteen HIV+ individ-
uals, which constitutes a major limitation regarding the possi-
ble widespread applicability of our findings. Additionally, our
treated S2 bleeds were taken after only approximately 3months
of antiretroviral therapy, which might be considered a relatively
short time period to observe immune reconstitution in adult
humans, given their reduced thymic output. However, we do
observe a significant recovery in CD4 cell numbers over this
period, in agreement with studies tracking CD4 cell numbers
in larger cohorts of patients, which often show that the first
3months of treatment produce the greatest absolute and relative
CD4 T-cell recovery (69, 70). A related sampling limitation is that
concerning the difference in number of different TCR sequences
obtained from either HIV+ individuals or uninfected controls,
whichmakes their analysis non-trivial. One can try to address this
by randomly selecting equally sized samples from both groups, yet
this results in analyses effectively including a higher proportion of
rare events from the HIV+ data.
One of the major strengths of the approach described in this
study is that all findings are derived from a fraction of RNA
extracted from a small sample of peripheral blood. These samples
are easily taken and stored, and using whole blood obviates the
need to fractionate different cell populations, avoiding the cost,
technical barriers, and health risks involved in processing poten-
tially infectious biological material. However, this arrangement
also imposes limitations on the depth of repertoire sequencing
and the ability to separate out dynamics of different T-cell pop-
ulations. If required – for instance to track rare T-cell clones –
depth could be increased in future studies by taking more blood,
processing more RNA or sequencing final libraries more deeply,
yet as many of the interesting phenomena discussed here were
manifest at a population structure level, this may not be required.
Subpopulation information might also be inferred from corre-
lations with routine clinical blood counts, as presented here, or
might even be estimated from the properties of the TCR chains
themselves, especially in the case of CD4 and CD8 T-cell sequence
differentiation as their repertoires show marked divergence in
several respects (71). This sequencing protocol could of course
also be applied to sorted cell populations were such data required.
Another limitation of the data presented here is one which affects
the majority of the high-throughput TCR repertoire published
data sets, thus far, in that we do not know which alpha chains
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pair with which betas in our samples. Such data would allow the
determination of actual clonotypes and would permit cloning and
functional testing of sequences of interest. However, while there
are a number of protocols which potentially offer this ability –
involving single-cell sorting (72), cellular emulsion PCR (73), in-
cell nucleic acid linking (74), or bioinformatic inference of paired
chains (75) – none are yet capable of producing data from the
same volume of cells as bulk sequencing without large increases
in handling time or cost.
This study therefore demonstrates a means by which TCR
repertoire sequencing even from small, unfractionated blood sam-
ples – collection of which could be readily incorporated into a
number of clinical studies – can be used to investigate a wide vari-
ety of immune parameters. Our results confirm and build upon a
number of previous studies investigating repertoire perturbation
during HIV infection. We are able to simultaneously track reper-
toire diversity, gene usage, and specific sequences in the data pro-
duced from a single experiment. These data highlight the dynamic
nature of the repertoire, which is rapidly reshaped following the
ART-induced fall in HIV load. These dynamic changes may lead
to improved immune function despite a persistent contraction of
the repertoire. In contrast, long-term damage to the repertoire
may be much more difficult to repair and may contribute to
long-term morbidity. Further studies, following larger cohorts of
HIV+ individuals through the various phases of HIV infection
and after long-term therapy, will help determine the clinical and
immunological correlates of perturbation of the TCR repertoire.
These data will help inform a rational approach to treatment opti-
mization andmay offer novel biomarkers for patient stratification.
Moreover, this study demonstrates the potential of TCR repertoire
sequencing for monitoring patients with infectious or immunod-
eficient diseases.
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